drugset
drugset / Trial / NCT00160147

Treatment of Elderly Subjects With Psychosis and Behavioral Disturbances Associated With Dementia of the Alzheimer's Type

NCT00160147 ↗

Phase 3 Terminated 60 enrolled Solvay Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a 10-week study with bifeprunox and placebo in elderly subjects with psychosis and behavioral disturbances associated with dementia of the alzheimer's type.

Timeline

Start
2005-12
Primary completion
2008-01
Completion
2008-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Bifeprunox Small molecule — —

Indications

psychotic disorder